Sopra Steria Group SA (SOP)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 185.00 |
|---|---|
| 52-week range | 109.40 – 202.20 |
| Return, 1 month / 3 months | +13.2% / +26.0% |
| Return, 1 year / 3 years | +38.3% / +15.9% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 42.7% |
| Worst drawdown (1 year) | -29.3% |
| Average daily value traded | 7.30M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sopra Steria Group is a French information technology services company based in Paris. It provides consulting, systems integration, software development and business process services to clients in banking, insurance, defence, aerospace and the public sector. The company helps organisations modernise their computer systems and adopt digital tools, and it also offers its own software products for areas such as human resources and banking. Its customers include large corporations and government bodies, mainly in Europe.
On this site Sopra Steria Group SA appears as a stock on the Euronext Paris (France), code SOP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sopra Steria Group SA (SOP) trades on the Euronext Paris in France. It last closed at EUR 185.00 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 34 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.3% and over the last three months it rose 26.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.4% | ||
| From 52-week high | -5.4% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.0% | ||
| 6-month return | 58.7% | ||
| 12-month return, skipping the last month | 22.1% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.3% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 7.30M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | +13.2% |
| 3 months | +26.0% |
| 6 months | +58.7% |
| 1 year | +38.3% |
| 3 years | +15.9% |
| 5 years | +25.4% |
Signals
| 50-day / 200-day average | 170.60 / 146.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jun 2026 | EUR 5.3000 |
| 3 Jun 2025 | EUR 4.6500 |
| 28 May 2024 | EUR 4.6500 |
| 29 May 2023 | EUR 4.3000 |
| 7 Jun 2022 | EUR 3.2000 |
| 1 Jun 2021 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.